Meningioma is a tumour arising from the meninges — the protective membranes surrounding the brain and spinal cord — and is the most common type of primary brain tumour diagnosed. The great majority (roughly 80-85%) are WHO Grade I, meaning they are benign, slow-growing, and often present for years before causing symptoms; a smaller proportion are atypical (Grade II) or, rarely, malignant (Grade III) with a greater tendency to recur or grow more aggressively. Meningiomas occur roughly twice as often in women as men, with incidence rising after middle age, and are sometimes discovered incidentally on brain imaging performed for an unrelated reason. Despite usually being benign, meningioma still requires neurosurgical evaluation, since growth, location, and pressure on surrounding brain tissue determine whether monitoring, surgery, or radiotherapy is appropriate; homeopathy's role, where used, is strictly supportive and never a treatment for the tumour itself.
Understanding Meningioma
Because meningiomas grow from the outer covering of the brain rather than brain tissue itself, they often grow slowly for years, gradually compressing adjacent brain structures rather than invading them directly, which is why symptoms — when present — tend to develop gradually rather than suddenly. Symptoms depend heavily on tumour location and size: headache, seizures, visual changes, weakness, personality or memory change, and hearing changes can all occur depending on which part of the brain is compressed. Many small meningiomas are discovered incidentally and cause no symptoms at all, found only because a scan was performed for another reason.
Why Meningiomas Are More Common in Women
The roughly two-to-one female predominance in meningioma, along with observations that some meningiomas grow faster during pregnancy and express hormone receptors (particularly progesterone receptors) on their cells, points to a hormonal influence on tumour growth, though the exact mechanism is not fully understood. This hormonal link is one of several distinct features that separate meningioma from other primary brain tumours, and is part of why some slow-growing, asymptomatic meningiomas are managed with a 'watch and wait' approach involving regular MRI monitoring rather than immediate intervention — a strategy less commonly available for other, more aggressive tumour types.
Diagnosis and the Treatment Pathway
MRI with contrast is the key diagnostic tool, often showing a characteristic appearance that allows a confident presumptive diagnosis even before biopsy. Management is decided by a neurosurgical team based on tumour size, growth rate, location, and whether it is causing symptoms: small, asymptomatic, slow-growing meningiomas are often simply monitored with periodic imaging; larger or symptomatic tumours, or those in a location amenable to safe removal, are typically treated with surgical resection, which is often curative for Grade I disease; tumours in surgically difficult locations, or atypical/malignant grades, may need radiotherapy or a combined approach. This pathway, guided by neurosurgery and neuro-oncology, is what determines outcomes.
Where Supportive Homeopathy Fits
For patients on a watch-and-wait monitoring pathway, awaiting surgery, or recovering from meningioma treatment, supportive homeopathy can help with headache, treatment-related fatigue, sleep disruption, and the anxiety that understandably accompanies a brain tumour diagnosis, even a typically benign one — always as an adjunct to, never a substitute for, neurosurgical monitoring and care. Homeopathy plays no role in shrinking a meningioma or determining its growth rate, and any new or worsening neurological symptom during a watch-and-wait period must be reported to the treating neurosurgeon promptly rather than managed with a remedy alone. Ignatia Amara suits the acute shock and suppressed emotion following diagnosis, Gelsemium addresses dread and trembling before scans, and Phosphorus supports general vitality and resilience for patients recovering from surgery or radiotherapy.
Key Points at a Glance
Roughly 80-85% of meningiomas are benign, slow-growing WHO Grade I tumours, though grading still requires specialist evaluation
Meningioma is about twice as common in women, likely reflecting a hormonal influence on tumour growth
Small, asymptomatic meningiomas are often managed with periodic MRI monitoring rather than immediate surgery
Homeopathy does not shrink or affect meningioma growth — it offers supportive care for symptom burden and anxiety only
Any new or worsening neurological symptom during monitoring needs prompt neurosurgical reassessment, not home management
Supporting a meningioma diagnosis alongside your neurosurgery team?
Dr. Meera Thakur offers constitutional homeopathic support for headache, fatigue, and anxiety at HealthKunj Clinics, Kharadi, Pune — always as an adjunct to your neurosurgical monitoring or treatment.
Book Your Consultation
Dr. Meera Thakur
BHMS · HealthKunj Clinics, Kharadi, Pune· Published 22 Aug 2026
Dr. Meera has 15+ years of experience in individualised homeopathic practice with a special interest in women's hormonal health, skin disorders, and paediatric care.
Read full profile